BioHealth News Archive
NIH announces $1 million prize competition to target global disease diagnostics
The National Institutes of Health has launched a $1 million Technology Accelerator Challenge (TAC) to spur the design and development of non-invasive, handheld, digital…
Read More
Can you catch Covid-19 from someone without symptoms? — Quartz
On Monday, June 8, an official at the World Health Organization (WHO) made a surprising statement. People who have Covid-19 but are asymptomatic—meaning they…
Read More
KaloCyte raises $300K from Maryland Momentum Fund – Technical.ly Baltimore
Less than a year after relocating its headquarters to Baltimore, biotech company KaloCyte has raised new funding from Maryland-based investors and expanded its local team.…
Read More
PathSensors Inc. Announced the Completion of Phase I of a SBIR
PathSensors Inc., a Baltimore biotechnology company, announced today the completion of Phase I of a Small Business Innovation Research (SBIR) program funded by the…
Read More
Covid-19 vaccine price controls would scare off developers, Fauci says at BIO – MedCity News
As multiple companies work to develop vaccines against the virus that causes Covid-19, it will be important for them to work with the federal…
Read More
Johns Hopkins to resume on-campus lab research next week | Hub
Johns Hopkins University researchers will be permitted to resume on-site laboratory activities beginning next week, the first steps of a gradual resumption of on-campus…
Read More
Maryland Stem Cell Research Commission Announces over $7 Million in awards to Accelerate Cures | MSCRF
COLUMBIA, Md. (June 5, 2020)— The Maryland Stem Cell Research Commission (Commission) has approved funding to its second round of 2020 recipients for a total…
Read More
SilcsBio and Dalriada Drug Discovery Launch Partnership to Create a Rapid Drug Discovery Service Suite | Press Release | I95 Business
June 11, 2020, Baltimore, MD and Toronto, ON – SilcsBio, a technology company that develops innovative software and provides services for structure-based drug design, and Dalriada Drug…
Read More
2020 AURP BIO HEALTH CAUCUS – Supporting the Growth of Bio Health Innovation Districts Worldwide – RECAP
At AURP’s BIO Health Caucus, we explored trends in life science research, opportunity zone funding resources, the marriage of life science and philanthropy in…
Read More
Immunomic Therapeutics to Present at AACR Virtual Annual Meeting II – Immunomic Therapeutics
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc. will present preclinical data on its investigational nucleic acid platform, UNITE (UNiversal Intracellular Targeted Expression), that elicits potent immune…
Read More
AstraZeneca taps Emergent as U.S. partner for potential COVID-19 vaccine – Reuters
AstraZeneca has inked manufacturing deals globally to meet its target of making 2 billion doses of the vaccine, including with two Bill Gates-backed ventures…
Read More
Covid-19 roundup: Fauci talks pricing, disparate impact and the virus’s enduring mysteries; China to offer experimental vaccines to overseas workers – Endpoints News
Multiple vaccines will ultimately be approved for Covid-19, NIAID chief Anthony Fauci told BIO yesterday, and the companies that make them should be allowed…
Read More
The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life | BIO
This ninth biennial TEConomy/BIO report focuses on the economic footprint of the industry geographically including the latest trends in the bioscience industry for the…
Read More
Congratulations to Our Digital RESI June Innovation Challenge Winners! | Next Phase Newsletter
Our 3-day Digital RESI June conference came to an end yesterday, and we are very excited to announce the Top 3 Winners of the…
Read More
AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine | FiercePharma
AstraZeneca made waves last week when it signed a massive $750 million deal to ramp production of a University of Oxford COVID-19 vaccine up…
Read More